Trial Outcomes & Findings for Verification of Prediction Algorithm (NCT NCT02863666)
NCT ID: NCT02863666
Last Updated: 2024-05-13
Results Overview
The number of any cardiopulmonary event, not limited to: Cardiac arrest Sustained ventricular tachycardia (VT) Hypotension requiring inotropes or intra-aortic balloon pump (IABP) insertion Intubation or mechanical ventilation Complete heart block Bradycardia requiring insertion of a pacing wire or external pacing, and Percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG)
COMPLETED
673 participants
Within 72 hours of presentation to ED
2024-05-13
Participant Flow
Participant milestones
| Measure |
Enrolled
Enrolled subjects in observational study
|
|---|---|
|
Overall Study
STARTED
|
673
|
|
Overall Study
COMPLETED
|
673
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Verification of Prediction Algorithm
Baseline characteristics by cohort
| Measure |
Enrolled
n=673 Participants
Enrolled subjects in observational study
|
|---|---|
|
Age, Continuous
|
58.8 years
STANDARD_DEVIATION 14.95 • n=5 Participants
|
|
Sex: Female, Male
Female
|
304 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
369 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
8 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
665 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
6 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
167 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
471 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
29 Participants
n=5 Participants
|
|
Region of Enrollment
Belgium
|
253 participants
n=5 Participants
|
|
Region of Enrollment
United States
|
420 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Within 72 hours of presentation to EDThe number of any cardiopulmonary event, not limited to: Cardiac arrest Sustained ventricular tachycardia (VT) Hypotension requiring inotropes or intra-aortic balloon pump (IABP) insertion Intubation or mechanical ventilation Complete heart block Bradycardia requiring insertion of a pacing wire or external pacing, and Percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG)
Outcome measures
| Measure |
Enrolled
n=673 Participants
Enrolled subjects in observational study
|
|---|---|
|
Number of Subjects With a Cardiopulmonary Event
|
145 Participants
|
SECONDARY outcome
Timeframe: Within 72 hours of presentation to EDThe cumulative number of any cardiac and cardiac-related events, not limited to: In-hospital Death In-hospital Cardiac Arrest Composite cardiovascular outcome or intervention (Lethal Arrhythmias , Acute Pulmonary Edema, Cardiogenic Shock, Myocardial Infarction, Percutaneous Coronary Intervention, Coronary artery Bypass Surgery , New or Recurrent MI, Recurrent Ischemia requiring Revascularization)
Outcome measures
Outcome data not reported
Adverse Events
Enrolled
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Enrolled
n=673 participants at risk
Enrolled subjects in observational study
|
|---|---|
|
Respiratory, thoracic and mediastinal disorders
Respiratory
|
0.74%
5/673 • Number of events 5 • 1 year, 4 months
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place